Theodore R Schroeder Nabriva Therapeutics PLC (NBRV) insider trading activity

Theodore R Schroeder is Director of Nabriva Therapeutics plc. Currently has a direct ownership of 11,989 shares of NBRV, which is worth approximately $4,795. The most recent transaction as insider was on Feb 06, 2021, when has been sold 2,695 shares (Ordinary Shares) at a price of $2.9 per share, resulting in proceeds of $7,816. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 12K

0% 3M change

0% 12M change

Total Value Held $4,795

Theodore R Schroeder Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Feb 06 2021	SELL Payment of exercise price or tax liability	$7,816 $2.9 p/Share	2,695 Reduced 1.48%	178,985 Ordinary Shares
Jan 31 2021	SELL Payment of exercise price or tax liability	$327 $2.62 p/Share	125 Reduced 0.07%	181,893 Ordinary Shares
Jan 29 2021	BUY Grant, award, or other acquisition	-	117,500 Added 39.23%	182,018 Ordinary Shares
Dec 31 2020	SELL Payment of exercise price or tax liability	$293 $2.42 p/Share	121 Reduced 0.19%	64,518 Ordinary Shares
Nov 30 2020	SELL Payment of exercise price or tax liability	$521 $0.43 p/Share	1,211 Reduced 0.19%	646,396 Ordinary Shares
Oct 31 2020	SELL Payment of exercise price or tax liability	$606 $0.5 p/Share	1,211 Reduced 0.19%	647,607 Ordinary Shares
Sep 30 2020	SELL Payment of exercise price or tax liability	$642 $0.53 p/Share	1,211 Reduced 0.19%	648,818 Ordinary Shares

Also insider at

OTIC

OTONOMY, INC. Healthcare

Director

CDTX

Cidara Therapeutics, Inc. Healthcare

Director

TRS